Medical Device and Diagnostic Industry (MD+DI): Boston Scientific Eyes Market Expansion with Watchman FLX After CHAMPION-AF Success Marian Regional Medical Center has successfully completed its 500th Watchman procedure, a milestone in providing advanced treatment options for patients with atrial fibrillation (AFib). The Watchman ... Cooperstown, N.Y.-based Bassett Medical Center’s interventional cardiology team has completed its 100th Watchman heart procedure.
The program originally launched in 2020. The Watchman prevents blood ... CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in patients with atrial fibrillation. Fierce Biotech: Boston Scientific’s Watchman heart implant measures up to blood thinners in ACC trial Boston Scientific’s Watchman heart implant measures up to blood thinners in ACC trial Yahoo Finance: CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and ...
watchman medical, Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary safety and efficacy endpoints. The study evaluated the WATCHMAN FLX™ ...
